STAAR Surgical (STAA)
NASDAQ: STAA
· Real-Time Price · USD
18.68
-0.09 (-0.48%)
At close: May 23, 2025, 3:59 PM
18.68
0.03%
After-hours: May 23, 2025, 04:06 PM EDT
STAAR Surgical Revenue Breakdown
| Period Ending | Dec 27, 2024 | Dec 29, 2023 | Dec 30, 2022 | Dec 31, 2021 | Jan 1, 2021 | Jan 3, 2020 | Dec 28, 2018 | Dec 29, 2017 | Dec 30, 2016 | Jan 1, 2016 | Jan 2, 2015 | Jan 3, 2014 | Dec 28, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Surgical Products Revenue | 1.36M | 1.85M | 269.71M | 212.91M | 141.41M | 129.32M | 101.08M | 68.33M | 59.11M | 51.54M | 44.05M | 44.13M | 35.08M |
| Other Surgical Products Revenue Growth | -26.55% | -99.31% | +26.68% | +50.56% | +9.34% | +27.94% | +47.94% | +15.59% | +14.68% | +17.02% | -0.18% | +25.79% | n/a |
| Implantable Collamer Lenses Revenue | 312.54M | 319.43M | 5.04M | 5.05M | 8.48M | 5.17M | 6.68M | 5.03M | 3.62M | 5.72M | 6.6M | 3.93M | 2.73M |
| Implantable Collamer Lenses Revenue Growth | -2.16% | +6236.58% | -0.14% | -40.46% | +63.88% | -22.53% | +32.84% | +39.09% | -36.83% | -13.34% | +67.87% | +44.00% | n/a |
Revenue by Geography
| Period Ending | Dec 28, 2018 | Dec 29, 2017 | Dec 30, 2016 | Jan 1, 2016 | Jan 2, 2015 | Jan 3, 2014 | Dec 28, 2012 |
|---|---|---|---|---|---|---|---|
| China Revenue | 46.07M | 23.88M | 16.02M | 12.57M | 9.37M | 20.47M | 19.55M |
| China Revenue Growth | +92.91% | +49.08% | +27.43% | +34.16% | -54.23% | +4.73% | n/a |
| Japan Revenue | 23.15M | 17.42M | 17.33M | 16.98M | 19.11M | n/a | n/a |
| Japan Revenue Growth | +32.87% | +0.55% | +2.04% | -11.12% | n/a | n/a | n/a |
| Other Countries Revenue | 47.42M | 35.87M | 31.77M | 22.99M | 19.57M | n/a | n/a |
| Other Countries Revenue Growth | +32.19% | +12.90% | +38.20% | +17.45% | n/a | n/a | n/a |
| United States Revenue | 7.32M | 7.89M | 9.86M | 10.9M | 11.12M | n/a | n/a |
| United States Revenue Growth | -7.32% | -19.93% | -9.58% | -1.92% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 28, 2025 | Dec 27, 2024 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 29, 2023 | Sep 29, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 30, 2022 | Sep 30, 2022 | Jul 1, 2022 | Apr 1, 2022 | Dec 31, 2021 | Oct 1, 2021 | Jul 2, 2021 | Apr 2, 2021 | Jan 1, 2021 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Jan 3, 2020 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 28, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 29, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 30, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | Jan 1, 2016 | Oct 2, 2015 | Jul 3, 2015 | Apr 3, 2015 | Jan 2, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 49.08M | 47.52M | 48.31M | 52.46M | 49.94M | 39.45M | 45.87M | 50.37M | 44.45M | 39.03M | 37.14M | 38.22M | 29.21M | 28.54M | 29.19M | 30.29M | 23.41M | 21.27M | 21.24M | 18.17M | 19M | 19.07M | 19.56M | 19.19M | 16.98M | 16.1M | 16.71M | 16.86M | 13.59M | 13.45M | 11.38M | 12.08M | 11.89M | 10.35M | 12.13M | 12.11M | 16.14M | 10.77M | 11.14M | 10.57M | 10.78M | 9.87M |
| Selling, General, and Administrative Revenue Growth | +3.29% | -1.64% | -7.91% | +5.05% | +26.57% | -13.99% | -8.94% | +13.32% | +13.89% | +5.09% | -2.81% | +30.83% | +2.36% | -2.25% | -3.63% | +29.39% | +10.10% | +0.13% | +16.86% | -4.33% | -0.40% | -2.49% | +1.93% | +13.02% | +5.47% | -3.63% | -0.88% | +24.03% | +1.05% | +18.20% | -5.84% | +1.62% | +14.91% | -14.74% | +0.21% | -24.98% | +49.90% | -3.32% | +5.38% | -1.98% | +9.26% | n/a |
| Research and Development Revenue | 13.66M | 12.04M | 14.5M | 14.05M | 13.38M | 10.87M | 11.47M | 11.76M | 10.31M | 9.79M | 9.62M | 8.64M | 7.94M | 9.07M | 8.27M | 8.26M | 8.26M | 8.96M | 8.75M | 7.31M | 6.9M | 7.41M | 6.16M | 6.1M | 5.63M | 5.71M | 5.57M | 5.35M | 5.04M | 5.19M | 4.43M | 4.71M | 4.78M | 4.28M | 4.45M | 4.66M | 6.91M | 3.96M | 3.68M | 3.54M | 3.58M | 3.25M |
| Research and Development Revenue Growth | +13.46% | -16.93% | +3.15% | +5.04% | +23.14% | -5.27% | -2.42% | +14.02% | +5.31% | +1.81% | +11.35% | +8.75% | -12.47% | +9.68% | +0.13% | +0.01% | -7.80% | +2.37% | +19.70% | +5.99% | -6.90% | +20.35% | +0.95% | +8.22% | -1.23% | +2.42% | +4.19% | +6.01% | -2.87% | +17.23% | -6.01% | -1.48% | +11.88% | -4.00% | -4.42% | -32.54% | +74.35% | +7.52% | +4.19% | -1.20% | +10.29% | n/a |
| Sales and Marketing Revenue | 24.62M | 26.17M | 26.62M | 28.82M | 26.71M | 22.6M | 26.61M | 32.28M | 26.35M | 24.22M | 23.13M | 24.23M | 17.27M | 17.07M | 18.18M | 18.85M | 13.2M | 11.76M | 12.65M | 10.33M | 11.03M | 11.2M | 12.46M | 11.68M | 10.14M | 9.87M | 10.62M | 10.66M | 7.38M | 7.85M | 6.43M | 7.32M | 6.53M | 6.47M | 7.15M | 7.18M | 7.67M | 5.91M | 6.28M | 5.83M | 5.67M | 5.69M |
| Sales and Marketing Revenue Growth | -5.93% | -1.69% | -7.62% | +7.90% | +18.20% | -15.07% | -17.57% | +22.47% | +8.80% | +4.73% | -4.55% | +40.32% | +1.20% | -6.11% | -3.60% | +42.81% | +12.24% | -7.02% | +22.50% | -6.37% | -1.56% | -10.11% | +6.69% | +15.17% | +2.80% | -7.09% | -0.37% | +44.43% | -5.96% | +22.03% | -12.16% | +12.11% | +0.90% | -9.47% | -0.45% | -6.44% | +29.84% | -5.94% | +7.75% | +2.89% | -0.37% | n/a |